Determination of the mechanical properties of amorphous materials through instrumented nanoindentation

A novel methodology based on instrumented indentation is developed to determine the mechanical properties of amorphous materials which present cohesive-frictional behaviour. The approach is based on the concept of a universal hardness equation, which results from the assumption of a characteristic indentation pressure proportional to the hardness. The actual universal hardness equation is obtained from a detailed finite element analysis of the process of sharp indentation for a very wide range of material properties, and the inverse problem (i.e. how to extract the elastic modulus, the compressive yield strength and the friction angle) from instrumented indentation is solved. The applicability and limitations of the novel approach are highlighted. Finally, the model is validated against experimental data in metallic and ceramic glasses as well as polymers, covering a wide range of amorphous materials in terms of elastic modulus, yield strength and friction angle

Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide

International audienc

Cell mediated immune response to L5P in longitudinal study of heifers from naturally<em> Mycobacterium avium</em> subsp <em>paratuberculosis</em> infected herd

National audiencePeptidyl moiety of cell wall lipopentapeptide (L5P) specific of Mycobacterium avium subsp paratuberculosis (Map) is immunogenic and a target for specific humoral response in Map infected animals. A chemically synthesized L5P is able to induce specific cell mediated immune response (CMIR) in IFN-γ release assay (IGRA) in selected cows from Map infected herds comparatively to non-infected or M. bovis infected. Following these observations, the aim of this study was to evaluate if L5P was an antigen of early specific immune response and potentially a predictive tool of Map infection. 113 heifers of 6 herds were included in a two years’ longitudinal study: 71 animals from three Map culture-confirmed herds, 11 animals from a Map infected herd Silirum® vaccinated during the study and 31 animals from two certified Map free herds. The analysis of the CMIR was investigated by IGRA following whole blood stimulation with synthetic L5P or mycobacterium purified protein derivative (PPD) from M. avium (PPDa), M. bovis (PPDb), Map (PPDj) and M. phlei (PPDp). Humoral immune response was quantified by L5P-based ELISA using an internal procedure and two commercial Map kits. Moreover, bacilli excretion was estimated by isolation and culture from faecal sample. PPDs’ CMIR was more or less high depending of infected herds context, became high over 2 S/P ratio for 10/11 animals just after Silirum® vaccination and was low, less than 0.1 S/P ratio, in certified Map free herds. L5P CMIR was observed in 9 of 71 animals from Map culture-confirmed herds. These 9 animals with a L5P CMIR positive between 0.05 and 0.6 S/P ratio were from the same herd, knowing that L5P CMIR was previously detected in all included Map culture-confirmed herds. L5P CMIR was fluctuant as already described for PPD but was significantly correlated with PPDj CMIR. For 2 of the 9 animals, the L5P CMIR was predictive of the Map positive serology, whereas it was concomitant with seropositivity for 2 others and that for 5 animals was several times observed without seroconversion. And no seroconversion was observed in other herds. The continuation of this study would assess the predictive potential of L5P CMIR for paratuberculosis diagnosis

A specific lipopentapeptide produced by Mycobacterium avium subp. Paratuberculosis to develop useful diagnostic tools

National audienc

Lipopentapeptide induces a strong host humoral response and distinguishes Mycobacterium avium subsp. paratuberculosis from M. avium subsp. avium

Background: Many non-tuberculous mycobacteria synthesize abundant glycopeptidolipids (GPLs). These surface-located GPLs are involved in pathogenicity by interfering with the host immune system. In Mycobacterium avium subsp. avium (Mav), GPLs consist of a lipopeptide core composed of a tetrapeptide O-linked to mono- and oligo-saccharides. The biosynthesis pathway of the simplest GPLs is now relatively well understood and involves probably more than fifteen genes. Whereas it is very obvious that most, if not all, of the Mav isolates produce GPLs, the picture is not as clear for M. avium subsp. paratuberculosis (Map), the etiologic agent of Johne's disease in cattle, and several conflicting data have been produced. Methods: Biochemical analysis of a large set of characterized Map isolates showed that all Map strains tested produce a lipopentapeptide (L5P) instead of GPLs. To provide a genomic basis for the synthesis of this compound, the recently published genome sequence of Map was explored using in silico methods. Even though Map produces a lipopeptide rather than GPL, its genome contains nevertheless a locus highly similar to the GPL biosynthetic pathway of Mav. We showed that the module composition of the non-ribosomal protein synthase (Nrp) of Map, the enzyme involved in the synthesis of the peptidyl moiety, is dramatically different from that of other GPL producers such as M. smegmatis (Ms) and Mav and is in agreement with the amino acid content of the L5P. We also showed that the peptidyl moiety of the L5P is a target for a strong specific humoral response in Map infected animals. Conclusions: These genomic and biochemical differences may help to unambiguously distinguish Map from Mav and also from M. bovis, to reclassify related strains of the Map species and to allow the convenient and specific diagnosis of paratuberculosis

Specific IgG Response against <em>Mycobacterium avium paratuberculosis</em> in children and adults with Crohn's disease

International audienceBackground and Aims: Presence of serum antibodies against Mycobacterium avium paratuberculosis (MAP) in Crohn's Disease (CD) as a disease characteristic remains controversial. In the present work, we assessed antibody reactivity of serum and intestinal fluid against four distinct MAP-antigens, including the recently identified MAP-specific lipopentapeptide (L5P). Methods: Immunoglobulin concentrations and specificity against 3 non MAP-specific antigens: glycosyl-transferase-d (GSD), purified protein derivative from MAP (Johnin-PPD), heparin binding haemagglutinin (MAP-HBHA) and one MAP-specific antigen: synthetic L5P were determined by ELISA in gut lavage fluids from adult controls or patients with CD, and in sera of children or adult controls or patients with CD, ulcerative colitis or celiac disease. Results: Total IgA and IgG concentrations were increased in sera of children with CD but were decreased in sera of adults with CD, thereof specificity against MAP antigens was assessed by normalizing immunoglobulin concentrations between samples. In CD patients, IgG reactivity was increased against the four MAP antigens, including L5P in gut lavage fluids but it was only increased against L5P in sera. By contrast, anti-L5P IgG were not increased in patients with ulcerative colitis or celiac disease. Conclusions: A significant increase in anti-L5P IgG is observed in sera of children and adults with CD but not in patients with other intestinal inflammatory diseases. Anti-L5P antibodies may serve as serological marker for CD

An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis.

Anaphylaxis is a systemic acute hypersensitivity reaction that is considered to depend on allergen-specific immunoglobulin E (IgE) antibodies and histamine release by mast cells and basophils. Nevertheless, allergen-specific IgG antibodies have been proposed to contribute when the allergen is an abundant circulating large molecule, e.g., after infusions of therapeutic antibodies or dextran. Data from animal models demonstrate a pathway involving platelet-activating factor (PAF) release by monocytes/macrophages and neutrophils activated via their Fc gamma receptors (FcγRs). We hypothesized that such a pathway may also apply to small drugs and could be responsible for non-IgE-mediated anaphylaxis and influence anaphylaxis severity in humans. We prospectively conducted a multicentric study of 86 patients with suspected anaphylaxis to neuromuscular-blocking agents (NMBAs) during general anesthesia and 86 matched controls. We found that concentrations of anti-NMBA IgG and markers of FcγR activation, PAF release, and neutrophil activation correlated with anaphylaxis severity. Neutrophils underwent degranulation and NETosis early after anaphylaxis onset, and plasma-purified anti-NMBA IgG triggered neutrophil activation ex vivo in the presence of NMBA. Neutrophil activation could also be observed in patients lacking evidence of classical IgE-dependent anaphylaxis. This study supports the existence of an IgG-neutrophil pathway in human NMBA-induced anaphylaxis, which may aggravate anaphylaxis in combination with the IgE pathway or underlie anaphylaxis in the absence of specific IgE. These results reconcile clinical and experimental data on the role of antibody classes in anaphylaxis and could inform diagnostic approaches to NMBA-induced acute hypersensitivity reactions